Biotransformation and in vivo stability of protein biotherapeutics: impact on candidate selection and pharmacokinetic profiling.

Biotransformation and in vivo stability of protein biotherapeutics: impact on candidate selection and pharmacokinetic profiling.

Item
http://www.wikidata.org/entity/Q38221771
Biosynthetic Polymers as Functional MaterialsProtein stability: a crystallographer's perspectiveKey factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and developmentQuantitative whole-body autoradiography: past, present and future.In vivo biotransformations of antibody-drug conjugates.Bioanalytical approaches to assess the proteolytic stability of therapeutic fusion proteins.Ligand-Binding Assay Development: What Do You Want to Measure Versus What You Are Measuring?Strategic internal covalent cross-linking of TNF produces a stable TNF trimer with improved TNFR2 signaling.Searching for the Pareto frontier in multi-objective protein design.In vivo characterisation of a therapeutically relevant self-assembling 18 F-labelled β-sheet forming peptide and its hydrogel using positron emission tomography.
P2860

Biotransformation and in vivo stability of protein biotherapeutics: impact on candidate selection and pharmacokinetic profiling.

Item
http://www.wikidata.org/entity/Q38221771
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Biotransformation and in vivo ...... and pharmacokinetic profiling.
@en
type
label
Biotransformation and in vivo ...... and pharmacokinetic profiling.
@en
prefLabel
Biotransformation and in vivo ...... and pharmacokinetic profiling.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Biotransformation and in vivo ...... and pharmacokinetic profiling.
@en
P2093
P304
P31
P356
P433
P478
P577
P698